Five Herbs to Treat Cancer
There is a great deal of interest today about the use of Chinese herbs to treat cancer. This interest is caused for any reasons. Two reasons are (1) the high cost of former cancer treatments; and (2) the side effects of the synthetic drugs that are used in accepted cancer treatments.
It is leading to note that any rehabilitation for cancer should be discussed with the presiding physician. Some combinations of drugs and herbs can cause an adverse reaction.
It is also leading to note that the facts in case,granted here should not be carefully medical advice. It isn’t intended to replace the advice offered by your physician. This is merely information.
Dong ling cao: Dong ling cao was not listed in herbal dictionaries of early dynasties. It became available only in 1972. Dong ling cao is being used to treat cancer of the esophagus, breast, and liver, as well as for swelling of throat, insect bites, snake bites, and inflammation of the tonsils.
Yi yi ren (also called semen coicis): Yi yi ren is typically used to invigorate the function of the spleen and to sacrifice pain and swelling caused by arthritis. It is also used to relax diarrhea, to take off heat, and to facilitate the drainage of pus. Yi yi ren is used by Chinese herbalists to treat cancer of the lung or spleen.
Tu fu ling: In animal studies, tu fu ling has proven especially efficient in treating cancers in the urinary tract (bladder) and the liver.
Ling zhi: Ling zhi is used to improve the immune system. Specifically, ling zhi is known to growth monocytes, macrophages, T-lymphocyt cytokine, interleukin, tumor necrosis, and interferon.
Ren Shen: Ren Shen is a herb that is known to improve the immune system, and it helps to relax the side effects caused by chemotherapy and radiation therapy, as well.
Breast Cancer Survival Rate
When one talks of breast cancer and treatment, the secondary ask is its survival rate. Survival rates give patients an idea of the extent of their cancer as well as the treatments that are ready to them. We often hear of five-year survival rates for each stage of breast cancer, but what exactly is breast cancer survival rate?
Breast cancer survival can be described in the following ways:
- Period of time : 5 or 10 years, that a woman lives after diagnosis
- Risk of reoccurrence
- Risk of death when compared to others with the same illness
The first is the more popular method. Since the survival rate is generally categorized agreeing to stages, some points about the stages of breast cancer first.
Stage 0 cancer is the non-invasive type. Cancer cells remain within the walls of the place where they are discovered. For Stage I, the tumor is invasive and is about 2 centimeters long. Stage Iia cancer means that tumor is 2-5 centimeters. With Stage Iib cancer, the tumor may be less than 2 centimeters but a few axillary lymph nodes are affected. For Stage Iiia cancer, the tumor is more than 5 centimeters or it has reached more lymph nodes. Stage Iiib cancer is characterized by the tumor invading the breast skin, regardless of its size. Stage Iv cancer is the most developed form, where the cancer cells have moved far from the breast and have infected other organs of the body as well.
Stages are also described as early (Stages 0-Iia), later (Stage Iib and Iii) and developed (Stage Iv).
When diagnosed with breast cancer it is the stages that will settle the treatment plan.
Survival rates
In computing the survival rate, researchers take note of the division of women who survive for a exact duration of time, say, 5 years, after determination of breast cancer. The current survival rates for all breast cancer stages are:
- Five-year survival rate – 86%
- Ten-year survival rate – 76%
Women with no metastatic breast cancer have a 5-year survival rate of 96%, while those with metastatic breast cancer have a 5-year survival rate of 21%
Here are the 5-year survival rates agreeing to stage:
- Stage 0 – 100%
- Stage I – 100%
- Stage Iia – 92%
- Stage Iib – 81%
- Stage Iiia – 67%
- Stage Iiib – 54%
- Stage Iv – 20%
Remember that these are estimates only. Some verily live longer than 7 years, depending on the medication and lifestyle changes that they make. After 7 years survival rates decrease.
Other factors that affect survival
Preliminary studies have been conducted with regard to factors that can affect survival. There are promising results with respect to factors such as changing your diet and lifestyle. While the results are not conclusive yet, it still makes sense to sound a healthy lifestyle. While there is no direct association between practice and increased survival rate, studies showed that practice improved the ability of life of survivors, such as higher self-esteem, improved mood and best sleep patterns. The same holds true for group psychological therapy. Being able to express their feelings and preserve for other survivors had inescapable effects on their ability of life. Smoking increases the risk of the spread of cancer, as there may be metastasis of cancer from breast to lung.
The significance of early detection cannot be overemphasized. When detected early, the accurate treatment can then be administered and once treated, there is less risk for the cancer to spread or recur. That is why doctors and breast cancer advocates encourage regular testing and screening for all women. This is principal even after treatment because there is still a risk of recurrence.
Conduct a self breast exam monthly. If necessary, have clinical tests such as mammograms and Mri scans. Ask your doctor for more data on breast cancer and search the web for answers from experts.
Breast cancer survival rates are mere estimates. Some patients verily live longer than 5 or 7 years. Changes in diet and lifestyle can increase a patient’s survival rate. Live a healthy lifestyle by eating more fruits, vegetables and fiber, and avoid alcohol intake.
Do I Have Cancer?
Article 3: Let’S Learn The Cancer Language First
There are over 100 separate types of cancer. Each type of cancer can have separate symptoms, diagnostic tests and rehabilitation options. As a result, there are many terminologies and phrases that are used to narrate the type, symptoms and diagnosis of cancer, and rehabilitation methods. It is often very confusing as well as frustrating for the readers if too many curative jargons or terminologies are used in describing this condition. It is difficult for readers to understand the context of the topic or take any action, if required, after reading any narrative or book on cancers. As a result, the facts is often misinterpreted or not fully understood or comprehended.
In this 3rd narrative of my cancer series, I would like to explicate in very simple terms all phrases and terminologies used in describing a cancer. This will help readers in understanding the cancer terms, types of cancer, base diagnosis and rehabilitation terminologies, and the health personnel complicated in management of cancer. These are described in alphabetical order here.
Ablation: discharge or destruction of body part or tissue. Radiofrequency Ablation (Rfa) therapy involves destroying cancer tissue with heat. Rfa is commonly used in the rehabilitation of lung, liver and kidney tumors.
Adenocarcinoma: cancer that begins from lining of internal organs or from skin
Adenoma: a non-cancer tumor that starts from glands
Adenopathy: swollen glands
Adjunct or adjunctive therapy: another rehabilitation used together with traditional treatment. For example, radiotherapy is sometimes given after surgery to treat cancer as adjunctive treatment.
Anal: of anus, anal cancer
Anorexia: an abnormal loss of appetite for food.
Asbestos: a group of minerals that are found in the form of tiny fibres. It is used as insulation against heat and fire in buildings. Asbestos dust when breathed into the lungs can lead to cancer of lungs and mesothelioma.
Asthenia: feeling or weakness or lack of energy. This is base in late stage cancer.
Astrocyte: this is a type of cell in the brain or spinal cord. Astrocytoma is a tumor that begins in astrocytes.
Asymptomatic: having no signs or symptoms of disease. Most cancers are asymptomatic in the early stages.
Axillary lymph node dissection: discharge of lymph nodes in the axilla. This may be done in the rehabilitation of breast cancer.
B-cell lymphoma: A type of cancer that forms in B cells.
Barrett esophagus: this is a health where the cells lining the lower part of the esophagus have changed or been substituted by abnormal cells that could lead to cancer of the esophagus. The regurgitation of the contents of stomach into the esophagus over time can lead to Barrett esophagus.
Basal cells: they are small round cells found in the lower part of epidermis. The cancer that begins in the basal cells is called basal cell cancer or basal cell carcinoma.
Benign: not cancerous, also called non-malignant. Malignant tumor is a cancerous growth.For example, fibroadenoma is a benign tumor of breast whereas as adenocarcinoma is a malignant tumor of the breast.
Benign prostatic hyperplasia: this is a non-cancerous health of prostate where there is overgrowth of prostate tissue.
Biological therapy: this is a type of rehabilitation that uses substances made from living organisms or its products to boost or restore the capability of the immune principles to fight cancer. Examples of biological agents include vaccines, interleukins and monoclonal antibodies.
Biopsy: the discharge of cells or tissues from the cancer or suspected cancer area for test by a pathologist. This is the most sure way of diagnosing cancer.
Bone marrow ablation: This is a course that is used to destroy bone marrow using radiation or high doses of anticancer drugs. It is done before a bone marrow or blood stem cell transplant to kill cancer cells and bone marrow cells. This is a part of oppressive rehabilitation of some leukemias.
Bone marrow aspiration: this is a course in which a small sample of bone marrow is removed with a wide needle and syringe and sent to laboratory to check for cancer cells. If a small sample of bone with bone marrow inside it is removed, it is called bone marrow biopsy.
Bone marrow transplantation: A course that is used to replace bone marrow that has been destroyed by rehabilitation with high doses of anticancer drugs or radiation.
Bone metastasis: cancer that has spread to bone from the traditional (primary) site.
Brachytherapy: it is also called internal radiotherapy. In this type of radiation therapy, radioactive materials sealed in needles, seeds, catheters or wires are placed directly into or near a tumor.
Brca1 and Brca2: these are genes on chromosomes 17 and 13 respectively. A person who is born with changes (mutations) in Brca1 and Brca2 genes has higher risk of getting breast, ovaries and prostate cancer.
Breast reconstruction: a surgery that is done to rebuild the shape of the breast after removing breast.
Breast self-examination: a woman examines her breasts to check for lumps or other changes.
Bronchogenic carcinoma: cancer that begins in the tissue that lines or covers the airways of the lungs.
Cancer antigen 125 or Ca-125: a substance that may be found in high amounts in the blood of patients with safe bet types of cancer, together with ovarian cancer.
Cachexia: loss of muscle mass and body weight. Cachexia is seen in patients in late stage cancer.
Cancer: this is a health where there is uncontrolled agency of abnormal cells.
Carcinogen: any substance that causes cancer, for example, tobacco smoke contains more than 50 carcinogens. Benzene is a carcinogen for leukemias.
Carcinogenesis: it is a process whereby normal cells start changing into cancer cells.
Carcinoma: it is a cancer that begins in the skin or in tissues that line the internal organs of the body. For example squamous cell carcinoma of skin or adenocarcinoma of gallbladder.
Carcinoma in situ: these are abnormal cells (not cancer) but can come to be cancer cells and spread. They are also said to be in stage 0 of cancer for example, cervical carcinoma in situ.
Carcinoma of unknown traditional (cup): in this type of cancer, cancer cells are found in some parts of the body, but the place where the cancer cells first started to grow cannot be determined.
Cervical: of cervix, cervical cancer
Colostomy: colostomy is an performance that connects the colon to the exterior of the body through the abdominal wall.
Cryosurgery: this is a course in which tissue is icy to destroy abnormal cells. Liquid nitrogen or liquid carbon dioxide is used to freeze the tissues. It is also called cryotherapy or cryosurgical ablation.
Cyst: a sac in the body; cysts in the ovary are very common.
Cytotoxic drugs: drugs that kill cells.
Dilatation and curettage (D&C): this is a course where some tissues are removed from the lining of uterus or cervix. The cervix is first made larger (dilated) with a instrument called dilator and another instrument called cutrette is inserted into the uterus to take off the tissue. The removed tissue sample may be sent to laboratory to check for abnormal or cancer cells.
Debulking: this is the surgical discharge of as much of a tumor as possible. This type of performance is usually done to relieve symptoms of cancer in the late stages of the disease.
Dermal: of skin
Duodenal: of duodenum, duodenal cancer
Dysplastic nevi: it is also called atypical moles and have a tendency to develop into melanoma.
Endometrial: of endometrium, endometrial cancer
Esophageal: of esophagus, esophageal cancer
Euthanasia: the intentional killing of a person to end his/her sufferings. It is also called mercy killing.
Excision: discharge by surgery, for example, excision of melanoma from skin.
Familial adenomatous polyposis (Fap): this is an inherited health in which many polyps form on the inside walls of the colon and rectum. Fap increases the risk of colorectal cancers.
Familial atypical manifold mole melanoma syndrome (Fammm): this is an inherited health that increases the risk of melanoma and pancreatic cancer.
Familial cancer: cancers that occur in families more often than in normal population, for example, breast or colorectal cancer.
Fecal occult blood test (Fobt): this is a test to check for blood in the stool. This is a screening test for bowel cancer.
Fibroadenoma: this is a benign tumor of breast.
Fibroid: a benign tumor that arises from plane muscle, for example, uterine fibroid.
First-degree relatives: this includes the parents, brothers, sisters, or children of an individual.
Fistula: an abnormal chance or tube in the middle of two organs or in the middle of an organ and the exterior of the body.
Follow-up: monitoring a person’s health health over time after treatment.
Gardasil: this is a vaccine to preclude infections by human papillomavirus (Hpv) types 16, 18, 6 and 11. It is used to preclude cervical, vulvar, and vaginal cancers caused by these viruses.
Gastrectomy: an performance to take off all or part of the stomach.
Gastric: of stomach, gastric cancer
Gastric feeding tube: a tube that is inserted through the nose, down the throat and esophagus, and into the stomach to give liquid foods, liquids and drugs. Feeding tubes are often inserted in patients who have mouth, throat, neck and esophageal cancers, particularly when the surgery is allembracing or combined with radiotherapy or chemotherapy.
Gastrotomy or Peg tube: this type of tube is inserted directly into the stomach through an chance in the skin and abdominal wall. This type of tube can be used for long-term feeding.
Gene: genes are pieces of Dna and include the facts for manufacture a exact protein that is passed from parent to offspring. Genetic means associated to genes.
Genetic counselor: a health pro trained in counseling on the genetic risk of diseases. This may involve discussing the person’s personal and family curative history and may lead to genetic testing.
Genetic testing: this is analyzing Dna to look for genetic change (mutation) that may indicate increased risk for cancer.
Genital warts: these are raised growths in the genital areas caused by human papilloma virus Hpv) infection.
Germ cells: these are reproductive cells of the body and include egg cells in women and sperm cells in men. Tumors that arise from germ cells are called germ cell tumors.
Gleason score: this is a principles of grading prostate cancer tissue based on how it looks under a microscope. Gleason scores range from 2 to 10 and indicate how likely it is that a tumor will spread. A low Gleason score means the cancer tissue is less likely to spread whereas a high Gleason score means the cancer tissue is more likely to spread.
Hematuria: blood in the urine.
Hemoptysis: coughing out blood from the respiratory tract.
Hemorrhoid: swollen blood vessel, usually seen in the anus or the rectum
Hepatic: of liver, hepatic cancer
Hepatoblastoma: it is a type of liver cancer more base in infants and children.
Hepatocellular carcinoma: this is the most base type of liver cancer.
Hereditary nonpolyposis colon cancer (Hnpcc): this is an inherited disorder in which the affected individuals have a higher-than-normal chance of developing colorectal cancer.
High intensity focused ultrasound: (Hifu): this is a course in which high-energy sound waves are aimed directly at the cancer or abnormal cells. These waves originate heat and kill the abnormal or cancer cells. Some types of prostate cancers are treated with Hifu.
Histology: the study of cells and tissues under a microscope.
History: the signs and symptoms the outpatient may have for a single disease
Hysterectomy: an performance where uterus and/or cervix are removed. When both uterus and the cervix are removed, it is called a total hysterectomy. When only the uterus is removed, it is called a partial hysterectomy.
Immunotherapy: a rehabilitation that boosts body’s immune principles to fight cancer, for example, immunotherapy of bladder cancer with Bcg vaccine.
Implant: a substance or object that is put in the body as prosthesis, for example, breast implant after discharge of breast for cancer.
Intensity modulated radiation therapy (Imrt): this is a type of radiation therapy that uses computer-generated images to show the size and shape of the tumor and direct thin beams of radiation at the tumor from separate angles. This type of radiation therapy reduces the damage to wholesome tissue near the tumor.
In situ: means ‘in its traditional place’. Carcinoma in situ means the abnormal cells are found only in the place they were first formed and have not spread nearby.
Incidence of cancer: the whole of new cases of a cancer diagnosed each year.
Incision: a cut made in the body by a surgeon to achieve surgery.
Induction therapy: this is the preliminary rehabilitation given to sacrifice a cancer, for example, induction therapy for acute myeloid leukemia.
Intrathecal chemotherapy: rehabilitation in which anticancer drugs are injected into the fluid-filled space in the middle of the tissue that cover the brain and spinal cord.
Intravenous (Iv) chemotherapy: rehabilitation in which anticancer drugs are injected into a vein through a canula.
Labial: of lip
Laryngeal: of larynx, laryngeal cancer
Laser surgery: a surgical course that uses intense, narrow beams of light to cut and destroy cancer tissue.
Leukemia: a cancer that starts in blood forming tissues such as bone marrow.
Lymphedema: a health where extra lymph fluid builds up in tissues and causes swelling. This can be seen in the arm after breast operations.
Malignant: means cancerous. Malignancy is the term used to narrate malignant cells that invade and destroy tissues.
Mass: a lump. It can be benign mass or malignant mass.
Mastectomy: discharge of breast.
Medical oncologist: a physician who specializes in diagnosing and treating cancer using chemotherapy, hormonal therapy, biological therapy, and targeted therapy.
Mesothelioma: cancer arising from the mesothelial lining of the pleura (covering of lung)
Melanoma: the cancer that begins in melanocytes. base site is the skin but can also occur in the eyes.
Metastasis: the spread of cancer from one part of the body to another. The cancer that is formed by cells that have spread from traditional site is called metastatic cancer or metastatic tumor.
Mucosal: of mucosa, mucosal lining of vagina
Mutate: means ‘to change’. Mutation means change in Dna of a cell.
Nasal: of nose, nasal polyp
Neoplasia: it is an abnormal and uncontrolled cell growth.
Neoplasm: it is an abnormal mass of tissue. Neoplasms can be benign or malignant (cancer).
Nodule: it is a increase or lump or mass that can be benign or malignant.
Oncogene: this is a changed or mutated gene and may cause increase of cancer cells.
Oncology: the study of cancer
Oncologist: a physician who specializes in treating cancer.
Oral: of mouth, oral cancer
Ovarian: of ovary, ovarian cancer
Palliative therapy or treatment: this is the rehabilitation given to relieve the symptoms and sacrifice the suffering of cancer patient. Palliative care aims to improve the capability of life of patients.
Pancreatic: of pancreas, pancreatic cancer
Pharyngeal: of pharynx, pharyngeal cancer
Pap test: this is a course in which cells are scraped from the cervix and examined under a microscope. This test is done to detect cancer or to detect changes in the cervix that may lead to cancer.
Partial: not whole, partly, for example, partial gastrectomy which means part of stomach is removed.
Penectomy: surgery to take off part or the entire penis
Penile: of penis, penile cancer
Plastic surgery: a surgical course that improves the appearance of body structures. The person who does plastic surgery is called plastic surgeon. Plastic surgeons are complicated in many reconstruction surgeries of breast, vagina or face after cancer treatment.
Polyps: these are small growths that arise from mucous membrane of colon and rectum.
Precancerous (premalignant) is a health that may come to be cancer later.
Proctoscopy: test of the rectum using a proctoscope, inserted into the rectum.
Prognosis: the likely outcome of cancer. The diagnosis of most cancers in developed stage is poor.
Prophylactic surgery: this is a surgery to take off part of a body or organ with no signs of cancer but in an exertion to preclude improvement of cancer in that organ in future. For example, deterrent mastectomy or deterrent discharge of ovaries are sometimes done.
Prostatic: of prostate, prostatic cancer
Prostate-specific antigen (Psa): this is a protein produced by prostate gland. The level of Psa in blood may be increased in men who have prostate cancer or enlarged prostate.
Pulmonary: of lung
Radiation oncologist: a physician who specializes in using radiation to treat cancer.
Radiation physicist: a person who makes sure that the radiation engine delivers the right whole of radiation to the spoton site in the body.
Radiation therapist: a health pro who gives radiation treatment.
Radiofrequency ablation: a course that uses radio waves to heat and destroy abnormal and cancer cells.
Recurrent cancer: cancer that has come back after rehabilitation or after being undetectable for a duration of time. The cancer is said to have recurred.
Refractory cancer or unyielding cancer: cancer that does not acknowledge to treatment.
Regimen: it is a rehabilitation plan where the dosage, the schedule and the duration of rehabilitation is specified.
Relative survival rate: it is an estimated whole that compares the chances that a person with cancer will survive after the diagnosis or rehabilitation of a cancer with those who do not have the cancer. It is usually calculated in terms of 2, 5 or 10 years. For example, the 5-year relative survival rate for colorectal cancer in America, if detected and treated early, is 90%.
Remission: this means disappearance of or decrease in signs and symptoms of cancer. A cancer is said to be in faultless remission when there are no signs and symptoms of cancer; it is in partial remission if some signs and symptoms of cancer have disappeared.
Renal: of kidney, renal cancer
Resection: discharge of part or all of an organ.
Risk factor: a risk factor is something that increases the chance of developing a cancer. For example, smoking is a risk factor for many cancers.
Screening: checking for diseases when there are no symptoms of cancer. Examples of cancer screening tests include Pap tests, mammogram, and colonoscopy.
Sentinel lymph node: it is the first lymph node to which cancer is likely to spread from the traditional tumor.
Staging of cancer: this is doing examinations and tests to find out the extent of cancer in the body and also whether the cancer has spread to other parts of the body. Staging cancer helps to give best rehabilitation to the patient.
Stem cell: a cell from which other types of cells develop. For example, red blood cells develop from blood-forming stem cells.
Stent: it is a device that is placed in a body structure to keep it open. For example, a stent may be inserted in the bile duct if it is blocked by cancer of gallbladder.
Stoma: this is an chance made surgically from an area inside the body to the outside. For example, colostomy has a stoma in the abdominal wall.
Surgical menopause: a woman stops to have menstrual duration following discharge of her ovaries. This is seen in operations on cancers of ovaries or uterus.
Surgical oncologist: a physician who performs surgical procedures in cancer patients.
Systemic chemotherapy: rehabilitation of cancer with chemotherapy drugs that trip through bloodstream and reach cells all over the body.
Targeted therapy: a type of cancer rehabilitation that uses drugs or other substances to recognize and assault exact cancer cells.
Testicular: of testis, testicular cancer
Thermotherapy: rehabilitation of disease using heat.
Topical treatment: medicines that are applied on the exterior of the body, for example, Aldara cream is applied topically on the skin to treat basal cell cancer.
Ulcer: this is a break on the skin or in the lining of an organ. For example, an ulcer on the face may be a sign of basal cell carcinoma.
Urethral: of urethra, urethral discharge
Uterine: of uterus, uterine cancer
Urologic oncologist: a physician who specializes in treating cancers of the urinary system.
Vaginal of vagina, vaginal cancer
Visceral: of the viscera, viscera mean internal organs. Visceral pain is pain coming
Vulval or vulvar: of vulva, vulval pr vulvar cancer
Wart: a raised increase on the exterior of the skin or other organs.
Watchful waiting: This involves intimately watching a patient’s health but not giving any active treatment. This is used in safe bet cancers like prostate or myeloma where the cancer progresses very slowly.
Wedge resection: this is a surgical course where a triangular piece of tissue is removed in order to treat a cancer.
Malignant Mesothelioma
Malignant mesothelioma is an uncommon, but no longer rare, cancer that is difficult to diagnose and poorly responsive to therapy. Malignant mesothelioma is the most serious of all asbestos-related diseases.
A layer of specialized cells called mesothelial cells lines the chest cavity, abdominal cavity, and the cavity nearby the heart. These cells also cover the outer covering of most internal organs. The tissue formed by these cells is called mesothelium.
The mesothelium helps protect the organs by producing a special lubricating fluid that allows organs to move around. For example, this fluid makes it easier for the lungs to move inside the chest while breathing. The mesothelium of the chest is called the pleura and the mesothelium of the abdomen is known as the peritoneum. The mesothelium of the pericardial cavity (the “sac-like” space nearby the heart) is called the pericardium.
Tumors of the mesothelium can be benign (noncancerous) or malignant (cancerous). A malignant tumor of the mesothelium is called a malignant mesothelioma. Because most mesothelial tumors are cancerous, malignant mesothelioma is often naturally called mesothelioma.
Mesothelioma was recognized as a tumor of the pleura, peritoneum and pericardium in the late 1700′s. However it was not until much later, in 1960, that this particular type of tumor was described in more detail and even more importantly, its association with asbestos exposure was recognized. The first narrative linking mesothelioma to asbestos exposure was written by J.C.Wagner, and described 32 cases of workers in the “Asbestos Hills” in South Africa. Since than the association in the middle of mesothelioma and asbestos exposure has been confirmed in studies nearby the world.
The incidence of mesothelioma in the United States remains very low, with 14 cases occurring per million people per year. Despite these numbers the noticed threefold growth in mesothelioma in males in the middle of 1970 and 1984, is directly associated with environmental and occupational exposure to asbestos, mostly in areas of asbestos stock plants and shipbuilding facilities.
Although the disease is much more ordinarily seen in 60-year old men, it has been described in women and early childhood as well. The cause of the disease is not so well understood in these latter two groups, but there is some evidence of possible asbestos exposure for some of these cases as well.
Mesothelioma is one of the deadliest diseases known to man; the average life span of an inflicted man from the time of pathology until death is less than 24 months. It’s a disease that strikes practically 3,000 United States citizens each and every year; hard working people who have labored for a lifetime to provide for their families, doing the work that keeps this country running and a great place to live. They worked in factories, at shipyards, in mines, for the Us military, as engineers, as pipefitters, as steel workers, as auto mechanics, and in so many other professions. They came home to their loved ones exhausted and covered in dirt and dust; tired, but article that they had a job and were providing for their family. article that they were putting food on the table and a house over their loved one’s heads. article that they were working to make a good life for their families in this generation and the next…
But what they didn’t know was that while they were working so hard, they were not only moderately killing themselves, but those that they were working so hard to help; their family, their loved ones.
What is the mesothelium?
The mesothelium is a membrane that covers and protects most of the internal organs of the body. It is composed of two layers of cells: One layer immediately surrounds the organ; the other forms a sac nearby it. The mesothelium produces a lubricating fluid that is released in the middle of these layers, allowing enthralling organs (such as the beating heart and the addition and contracting lungs) to glide positively against adjacent structures.
The mesothelium has separate names, depending on its location in the body. The peritoneum is the mesothelial tissue that covers most of the organs in the abdominal cavity. The pleura is the membrane that surrounds the lungs and lines the wall of the chest cavity. The pericardium covers and protects the heart. The mesothelial tissue surrounding the male internal reproductive organs is called the tunica vaginalis testis. The tunica serosa uteri covers the internal reproductive organs in women.
What Is My Diagnosis?
There are three types of mesothelioma. Pleural mesothelioma is a cancer of the lining of the lung (pleura), peritoneal mesothelioma is a cancer of the lining of the abdominal cavity (peritoneum), and pericardial mesothelioma is a cancer of the lining surrounding the heart (pericardium). Sub-types (or cell types) of mesothelioma are epithelioid (the most common, and considered the most amenable to treatment), sarcomatous (a much more aggressive form), and biphasic or mixed (a compound of both of the other cell types).
The structural appearance of cells under the microscope decide the cell or sub-type of mesothelioma. Epithelioid is the least aggressive; sarcomatoid, the most aggressive. The biphasic or mixed cell type shows structural elements of both of the other two.
There are three types of mesothelioma. Pleural mesothelioma is a cancer of the lining of the lung (pleura), peritoneal mesothelioma is a cancer of the lining of the abdominal cavity (peritoneum), and pericardial mesothelioma is a cancer of the lining surrounding the heart (pericardium). Sub-types (or cell types) of mesothelioma are epithelioid (the most common, and considered the most amenable to treatment), sarcomatous (a much more aggressive form), and biphasic or mixed (a compound of both of the other cell types).
Vaccine connected Sarcoma in Cats
As early as 1990 veterinarians started finding more tumors in cats. There were suspicions that these tumors were vaccine connected sarcoma. In our vigilance to keep our cats free of disease are we assuredly causing them to have cancer?
A pathology of feline cancer can be devastating to a cat owner. Then to find out that it may be a vaccine connected sarcoma (malignant tumor) is even more crushing. There is addition evidence that our actions to keep a cat healthy may assuredly lead to feline cancer.
This phenomenon is now called vaccine connected sarcoma. The phrase “vaccine related” is beloved because there is positive proof that the vaccines cause the tumor. There may be something in the vaccine media that is assuredly prominent to the sarcoma in cats.
The bottom line is that tumors are found more oftentimes where vaccines are given. Sometimes the material used in a vaccine is assuredly found in some cat tumors. It’s all fairly hard to study because of the time that passes in the middle of the vaccination and when the tumor is discovered.
A vaccine join together sarcoma is a tumor that develops at the site of injection of a vaccination. It’s not known what causes the tumor; if it’s the vaccine or a substance mixed with the vaccine to encourage a stronger immune reaction that causes it.
It was if cat’s where getting cancer, but dogs didn’t. Cats that have experienced an injury to the eye have a greater opening of developing a sarcoma in the cat’s eye. Why dogs don’t have this problem, but cats do may be connected to the type of vaccine?
In the 80′s the feline leukemia vaccine became available. About the same time any states made rabies vaccinations mandatory. Veterinarians plainly gave the vaccines at the same time, normally in the same location on the cat’s body.
After cats started showing up in vet offices with tumors and vaccine connected sarcoma was suspected, vets started to move the injection spot to a dissimilar location for each vaccine. This would also help recognize if a feline cancer was connected to a vaccine location.
The Vaccine join together Feline Sarcoma task force advise that the rabies vaccine be given in the right rear leg, the leukemia vaccine in the left rear leg, and all other vaccines off the shoulder midline area. There was one other recommendation. One idea is to only vaccinate your cat with vaccines she needs. If you cat is a fully indoor cat, then there small risk of feline leukemia and she probably doesn’t need that vaccine.
There was one more hint that is most controversial. That hint was to give vaccinations less frequently. Vets are not so much implicated that a vaccine will ‘wear off’ if it’s given less oftentimes than they are that cat owners won’t bring in their cat to the vet for its yearly wellness exam.
As you can see, finding into the causes of feline cancer and vaccine connected sarcoma is a involved topic. There are both condition and monetary considerations for reducing the frequency of vaccinations in cats.
Throat Cancer
Smokers are at the top Risk of Developing Throat Cancer
If you are a smoker, consume alcohol on a frequent basis, or if you use chewing tobacco, you are at an increased risk of developing throat cancer. If you fall into any of these categories, (and even if you don’t), you may have developed throat cancer if you have any of the following symptoms: a sore throat, head or neck, feeling like there is a lump in your throat or neck, having a hard time swallowing, constantly clearing your throat and sounding like your voice is hoarse, and/or noticing a turn in the sound of your voice.
Being a smoker puts you at the most risk for developing throat cancer. Most (up to 95 percent) of throat cancer patients are or were smokers, and the more years you smoke the greater your risk.
Most cases of throat cancer can be prevented. Prevention is much more pleasant than undergoing the treatments, and guidance and suggestions on how to forestall throat cancer are ready from the American Cancer Society.
Other Throat Cancer Symptoms
There are other symptoms that may indicate you have throat cancer. Less definite symptoms of throat, head and neck cancer can comprise feeling like your headache never goes away, having a hard time taking a deep breath, noticing that your nose bleeds all the time, tooth pain, and unexplained swelling in general throat area.
Throat Cancer Treatments
Throat cancer can be treated in a whole of ways. Depending on the severity of the throat cancer, any mixture of the following may be used to treat it:
Surgery – The surgery complexity will depend on the severity and extent of damage caused by the throat cancer.
Radiation – The radiation dose will vary depending on the size of the throat cancer tumor.
Chemotherapy – Chemotherapy will attack the throat cancer cells and (hopefully) eliminate them. Side effects from chemotherapy are generally highly unpleasant.
Throat Cancer Can be Prevented
There are many factors that conduce to the risk of developing throat cancer. If you do all you possibly can to avoid smoking or breathing in second-hand smoke, and if you limit your alcoholic beverage intake, you will greatly reduce your risk of developing throat cancer.
Get Help from the American Cancer Society
If you conjecture that you may have throat cancer, the American Cancer society can be a good reserved supply for you. The society can furnish you with more data about throat cancer – symptoms, treatment, after-care, and general support. Remember, if you are a throat cancer patient, there is help available.
Liver Ascites
Ascites is the proximity of inordinate fluid within the peritoneal cavity. Individuals with ascites form corporeal exam findings of addition abdominal girth, a fluid wave, a ballotable liver, and shifting dullness. Ascites can form in patients with conditions other than liver illness, including protein-calorie malnutrition (from hypoalbuminemia) and cancer (from lymphatic obstruction).
In patients with liver disease, ascites is due to portal hypertension. It’s helpful to identify that liver disease with ascites formation occurs in a broad clinical spectrum. At a single end is fully compensated portal hypertension with no ascites present naturally because the amount of ascites generated is much less than the nearby 800-1200 mL/d ability from the peritoneal lymphatic drainage.
In the other extreme is the typically fatal hepatorenal syndrome, in which patients with liver disease, commonly with heavy ascites, succumb to rapidly progressing acute renal failure. The hepatorenal syndrome appears to come to be precipitated by intense and unacceptable renal vasoconstriction and is characterized by severe salt holding appropriate of prerenal azotemia but within the absence of true volume depletion.
Nonetheless, the proximity of clinically apparent ascites in a sick person with liver disease is related with poor long-term survival. Over the many years, discrete mechanisms have been proposed to interpret ascites formation. No single hypothesis of pathogenesis in fact explains all findings whatsoever points in time during the organic history of portal hypertension. Portal hypertension and unacceptable renal holding of salt are leading elements of all theories.
The end consequent of ascites happens when excess peritoneal fluid exceeds the capacity of lymphatic drainage, traditional to increased hydrostatic pressure. The fluid can then be observed to visibly weep from the lymphatics and pool within the abdominal cavity as ascites. The underfill/vasodilatation hypothesis proposes that the main event in ascites formation is vascular, with reduced sufficient circulating amount leading towards the activation of the renin-angiotensin ideas and subsequent renal sodium retention.
The excellent underfill hypothesis postulates that elevated hepatic sinusoidal pressure leads to sequestration of blood in the splanchnic venous bed. This outcomes in underfilling of the central vein with diversion of intravascular volume to the hepatic lymphatics, which, like the central vein, drain the space of Disse.
The peripheral arterial vasodilatation or splanchnic vasodilatation hypothesis adds the notion that, with portal-to-systemic shunting, vasodilatory items (eg, nitric oxide) that are ordinarily cleared by the liver are instead delivered towards the systemic circulation, exactly where they trigger peripheral arteriolar vasodilation, particularly within the splanchnic arterial bed.
The resultant reduced arterial vascular resistance is related with decreased central filling pressures, decreased renal arterial perfusion, reflex renal arterial vasoconstriction, and increased renal tubular sodium resorption. holding of salt expands the intravascular amount, which exacerbates portal venous hypertension.
The imbalance in the middle of hydrostatic versus oncotic pressure in the portal vein results in ascites formation. Even though the splanchnic vasodilatation hypothesis accounts for many from the findings in ascites formation, the use of transhepatic intrajugular portal-to-systemic shunting (Ideas) as a signifies of decompressing the portal vein in patients with ascites provides a counterargument.
As a consequent of the procedure, peripheral arteriolar vasodilation seems to heighten (perhaps consequently of shunting of vasodilators such as nitric oxide which are ordinarily cleared by the liver), however ascites is ordinarily dramatically improved. Population who sustain the overflow hypothesis have proposed how the traditional event within the correction of ascites is inappropriate renal salt retention.
In this view, ascites may be the consequence of overflow of fluid from the intravascular volume-expanded portal ideas to the peritoneal cavity. But what triggers the inappropriate renal salt retention? A single possibility is that there might exist a hepatorenal reflex by which elevated sinusoidal stress triggers increased sympathetic tone or endothelin-1 secretion.
Either of these pathways could cause an unacceptable degree of renal vasoconstriction, a decrease in glomerular filtration rate, and, by tubuloglomerular feedback, salt retention. Note that endothelin-1 is both a renal vasoconstrictor along with a stimulant of epinephrine secretion, which in turn stimulates more endothelin-1 secretion.
Alternatively, it’s potential that an as yet unidentified stock in the diseased liver interferes with atrial natriuretic peptide (Anp) activity at the kidney or is in some other way responsible for an inappropriate increase in renal sodium retention. Supporters from the overflow hypothesis point to the fact that numerous cirrhotic individuals have sodium handling defects within the absence of ascites and do not have a measurable increase in renin-angiotensin activity.
However, studies have shown that the renal salt holding in these individuals could be reversed by the use of an angiotensin Ii receptor antagonist. Most most likely, complicated mechanisms contribute to the development of ascites and to its perpetuation, worsening, or correction in diverse clinical situations.
Was Your Ovarian Cancer Misdiagnosed?
As many as 30,000 U.S. Women will be diagnosed with ovarian cancer this year. In 2006, between 15,000 and 16,000 women are likely to die from this silent killer. Ovarian cancer is the 5th important cause of death among women, and it is responsible for about five percent of all cancer deaths. Chances are your doctor may have misdiagnosed you. That is often the case. A up-to-date British study found 60 percent of all U.K. General practitioners had misdiagnosed their patients.
Three-quarters of British doctors surveyed incorrectly assumed that symptoms only occurred in the late stages of ovarian cancer. Based upon that information, it should be no surprise that Britain has one of the lowest survival rates for ovarian cancer in the Western World – of 6,800 cases diagnosed each year, more than 4,600 die.
A similar discovery was made by University of California researchers, who announced last year, “Four in 10 women with ovarian cancer have symptoms that they tell their doctors about at least four months — and as long as one year — before they are diagnosed.” agreeing to their study of nearly 2,000 women with ovarian cancer, the researchers discovered physicians:
o First ordered abdominal imaging or performed gastrointestinal procedures instead of the more suitable pelvic imaging and/or Ca-125 (a blood test that can detect ovarian cancer).
o Only 25 percent of patients, who reported ovarian cancer symptoms four or more months before diagnosis, were given pelvic imaging or had Ca-125 blood tests.
Patients with early symptoms are often misdiagnosed. Abdominal imaging or diagnostic gastrointestinal studies are less likely to detect ovarian cancer. agreeing to the American Cancer Society’s website, “The most base indication of illness is back pain, followed by fatigue, bloating, constipation, abdominal pain and urinary urgency. These symptoms tend to occur very often and come to be more severe with time. Most women with ovarian cancer have at least two of these symptoms.”
By the time a woman reaches the fourth stage of ovarian cancer, her first-line medicine is often Carboplatin, Paclitaxel and Cisplatin as the exact chemotherapy for ovarian cancer. In the first stage, cancer is contained inside one or both ovaries. By stage two, the cancer has spread into the fallopian tubes or other pelvic tissues, such as the bladder or rectum. When the cancer has spread outside the pelvis area into the abdominal cavity, especially when tumor growths are larger than two centimeters on the lining of the abdomen, then ovarian cancer has reached stage three. The fourth and final stage of ovarian cancer is reached when the cancer has spread into other body organs, such as the liver or lungs.
If detected early, survival rates can be as high as 90 percent. Detected in the industrialized stage, the survival rate falls to between 30 and 40 percent. Discrete imaging tests such as computed tomography (Ct) scans, magnetic resonance imaging (Mri) scans, and ultrasound studies can confirm whether a pelvic mass is present. A laparoscopy can help a doctor look at the ovaries and other pelvic tissue to in order to plan out a surgical procedure, or to decide the stage of the ovarian cancer. A biopsy, or tissue sampling, would confirm if there is cancer in your pelvic region, and would help decide how industrialized it is. An elevated Ca-125 blood test typically suggests the cancer has progressed to the industrialized stage.
About 50 percent of ovarian cancer patients are already at an industrialized stage by the time a accurate prognosis is made. Only 10 to 14 percent of women with industrialized cancer are likely to survive more than five years.
Evaluation of Therapies
While study shows drinking black (or green) tea or taking the herbal supplement gingko biloba may be useful, as a prophylactic measure, or to cut risk, a woman has few choices when her cancer has moved to the industrialized stage. In the first stage, a woman faces surgical discharge of the tumor, and maybe one or both ovaries, to growth her chances of survival. Beyond that, her choice is chemotherapy.
One major question with chemotherapy is the side effects. The more industrialized the cancer, the weaker one may be, reducing the survival rate potential. Survival rates have not changed very much over the past fifteen years. Chemotherapy can growth survival time by as much as 50 percent. But, quality of life suffers. The side effects and increased toxicity, with chemotherapy, cut how one spends the continued survival time.
Some of Paclitaxel’s minor side effects, as reported by Medline Plus, may consist of nausea, vomiting, loss of appetite, turn in taste, thinned or fragile hair, pain in the joints of the arms or legs, changes in the color of nails, and/or tingling in the hands or toes. More serious side effects may consist of mouth blistering or fatigue. Some alarming side effects could consist of unusual bleeding or bruising, dizziness, shortness of breath, severe exhaustion, chest pain, or difficulty swallowing. The most base side consequent of Paclitaxel is a decrease of blood cells.
Carboplatin has its own list of side effects. It can cut platelet production, which can interfere with your blood’s quality to clot. You may come to be anemic, feeling tired or breathless. Nausea, vomiting, loss of appetite and a General feeling of weakness are base with this chemotherapeutic agent.
The newest breed of drugs, such as Eli Lilly’s Gemzar, are hardly getting praise. On March 10th, the Food and Drug administration (Fda) said it was skeptical of the benefits Eli Lilly’s Gemzar, which was being used with Carboplatin to treat ovarian cancer patients. The Fda felt the 2.8 months increased survival time, in case,granted by the Gemzar/Carboplatin blend failed to offset the treatment’s increased toxicity.
In January, the New England Journal of medicine reported on a grand new delivery theory of chemotherapy, called the “intra-abdominal, or intraperitoneal, chemotherapy. Those who received the “belly bath” as it is now being called by the media can survive 16 months longer than those receiving intravenous chemotherapy. The major drawback is that 60 percent of the women in the study were unable to perfect all six cycles of this chemotherapy. Those who did survived longer, but only two in every five women were able to expand to the end phase of the therapy.
One novel approach, now in Phase Iii trials at more than 60 study centers across the United States, is OvaRex ® Mab, a murine monoclonal antibody, a type of biotech drug derived from mouse cells. It is being tested by extremely regarded United Therapeutics, based in Silver Springs, Maryland. Their lead drug Remodulin, an injection which treats pulmonary arterial hypertension, is currently being marketed inside and outside the United States. More than million has been spent researching, and on the improvement of, OvaRex and may have it ready on the market by 2008.
OvaRex was industrialized in Canada by a firm called ViRexx curative Corp, and first tested in that country. agreeing to Dr. Lorne Tyrrell, Chief menagerial of ViRexx, “The whole study has been set up with the Fda. This is a study where the drug has been given fast track approval and orphan drug status.” Dr. Tyrrell is also on leave (until OvaRex come to be commercially available) as a Professor of curative Microbiology and Immunology at the University of Alberta, and Director of the National Centre of Excellence for Viral Hepatitis Research.
OvaRex was tested in Canada, prior to the current Phase Iii trials in the U.S. “There have been a amount of patients that have received OvaRex,” said Dr. Tyrrell, “We’ve had in fact no adverse effects from these patients.” Dr. Tyrrell explained the procedure, “After being injected intravenously, OvaRex binds to an antigen circulating in the blood.” An antibody’s General purpose is to neutralize an antigen. After an OvaRex injection, the murine monoclonal antibody binds to the Ca-125 antigen.
In a way the body is tricked. But, the body is tricked in order to help “save” itself from the harmful antigen. When the OvaRex antibody is bound to the Ca-125 antigen, the new blend is identified as a harmful unit. Before then, the antigen wanders straight through the body, without alerting the body’s defense systems, the dendritic cells, to assault and destroy the harmful antigen. Because the body is trained to recognize and zero in on a foreign protein, in this case a mouse protein, it alerts the dendritic cells. Until then, the dendritic cells “tolerate” the cancerous cells. The tolerance is what permits the cancer to spread throughout the body.
OvaRex seeks to break that tolerance. The murine monoclonal antibody is designed to target and bind exclusively to free floating Ca-125 antigen.
The dendritic cells refuse to tolerate the foreign protein. When the antibody binds with the free-floating antigen, the dendritic cells recognize the complicated (antibody plus antigen) as being foreign and engulf the new unit. The dendritic cells break down the key proteins of this unit, presenting all parts on the cells surface. At the point, the body’s killer T-Cells are alerted to fight the internal threat to the body. Once activated, the T-Cells will replicate and create more killer T-Cells. Any tumor cells expressing the Ca-125 antigen is targeted for destruction. The army of T-Cells move to assault the ovarian cancer tumor.
The principle behind OvaRex is to re-program the immune theory to harness the body’s defenses to preclude the growth and spread of the ovarian cancer. Will it cure ovarian cancer? “In most cases, it will be a delay,” explained Dr. Tyrrell. “However, I think that, and every person hopes that, often in some of these tumors, you’re making incremental expand straight through meticulous clinical trials and adding new therapy. Each thing we do that improves the outcome when you start to look at the long term benefits of these, we hope that one day we will be able to cure this disease. We think this is a step. This has the possible to be an important step at helping to stimulate immune response to accomplish a best outcome. Hopefully, one day we can improve that to where it is a cure.”
Copyright © 2007 by StockInterview, Inc. All proprietary Reserved.
Microcalcifications and Early Signs of Breast Cancer
Breast calcifications are calcium deposits inside breast tissue. They emerge as white spots or flecks on a mammogram and are typically so small that you couldn’t feel them.
Breast calcifications are extensive in all women and are even more coarse after menopause. Though breast calcifications are typically noncancerous (benign), particular patterns of calcifications – like tight clusters with irregular shapes – might point to breast cancer.
The two major kinds of breast calcifications are:
- Macrocalcifications. They come out as large white dots or dashes on a mammogram. Macrocalcifications are nearly always noncancerous and need no additional follow-up.
- Microcalcifications. They come out as highly fine white specks on a mammogram. Microcalcifications are typically noncancerous but could sometimes be a sign of cancer.
Where and How Often Do Calcifications come out?
- macrocalcifications show up in practically 50 percent of women over 50, and 10 percent of women under 50 years of age
- macrocalcifications are typically not troublesome and won’t need a biopsy
- 80 percent of microcalcifications are benign
- microcalcifications could help identify ductal carcinoma in situ (Dcis)
A microcalcification is an growth of calcium in one spot. They are extensive and most women will have a few on their mammogram at some point in time. The majority of them are benign. A good number of women do worry regarding them, though – maybe since they haven’t been given a perfect solution of what they are.
When should you worry? First, don’t be frightened if you have microcalcifications since the majority women Do have them at some point. The doctor will take a look to eye if they warrant additional examination.
This typically happens when the microcalcifications are new, clustered firmly together, and comes out when magnified to have unusual forms. Rather than spherical, they look similar to grains of salt with irregular edges. This could be an early sign of breast cancer, most frequently non-invasive ductal carcinoma in situ (Dcis or stage 0 breast cancer).
Microcalcifications couldn’t be experienced on clinical exam or your own breast self-exam. They do not harm. This is the value of mammography – it finds them long prior to they could move forward into an actual lump.
Most of the time, suspicious microcalcifications will be biopsied by means of a stereotactic recipe that enables the doctor to pin down their location and take away a sample consequently it could be examined by a pathologist. The intention of removing tissue by means of this recipe is not to get rid of all of the microcalcifications but to collect a representative sampling accordingly a analysis could be completed.
Breast Cancer The Cure
You have my permission to issue this article electronically or in print, free of charge, as long as the bylines are included. A courtesy copy of your publication would be appreciated.
Breast Cancer The Cure
There is no known cure for breast cancer. More than 1.5 million habitancy will be diagnosed with breast cancer this year worldwide. Scientists don’t know why most women get breast cancer, yet breast cancer is the most frequent tumor found in women the world over. A woman who dies of breast cancer is robbed of an average of nearly 20 years of her life. Breast cancer knows no collective boundaries. It’s a disease that can influence anyone. Some prominent women who’s lives that have been touched by breast cancer include Jill Eikenberry actress age 52; Peggy Fleming age 49 figure skater; Kate Jackson age 50 (Charlies Angels); Olivia Newton-John age 50 actress singer; Nancy Reagan age 77 previous first lady; Melissa Etheridge age 43 singer; and the gorgeous Suzanne Summers actress. These high rates of breast cancer are not accepted to the women of the world and must be met with scientific explore that provides results.
Despite over a decade of research, and more than .7 billion spent, hundereds of women worldwide are dying from breast cancer every day. Yet doctors don’t know how breast cancer starts or how to cure it. Doctors are still approaching rehabilitation for breast cancer in the same old fashioned ways: surgery, radiation, and chemotherapy. Barbarick treatments…And scientists keep doing the same old redundant explore that’s naturally not working. It doesn’t have to be that way. Gen Cells Cures is a scientific biotechnology firm that is focused on a cure for breast cancer. The firm is dedicated to curing breast cancer before it’s too late for you. We’re not concerned in a cure in five, ten, or twenty years from now. We want your cure for breast cancer within a year or two. We don’t want you to have to under go surgery, radiation, chemotherapy or take toxic drugs.
Why Gen Cells Cures? You can hunt the medical journals; you can hunt the internet until your blue in the face. You will find the same old news which is no new news about breast cancer explore and treatments. Breast cancer explore is locked up in a black whole. Gen Cells Cures is approaching the cure for breast cancer from dissimilar angles and using tomorrow’s scientific technologies today. Our expertise is in stem cell explore and genomics. Malfunctioning stem cells have already been related to the improvement of breast cancer. We’re not talking about using generic stem cells from an egg and sperm cell. There is no genetic match for you with the politically controversial generic stem cells that are all the time in the news. The isolation of cancer stem cells, coupled with our understanding of genetic mutations causing cancer, and our knowledge of genomics will follow in ways to eliminate cancer cells while sparing normal breast tissues.
Genetics and Breast Cancer
People will tell you to accept what you can’t change…Your genetics, your genes, the genes your mom and father handed you when you were born that came with their singular genetic make-up. Most inherited cases of breast cancer have been related with two genes: Brca1 and Brca2. The past five years has been a period of unparalleled discovery in the field of genetics, genomics, and stem cell research, but these discoveries are not being applied to breast cancer treatments. A job that Gen Cells Cures absolutely wants to get our hands dirty in. Recently researchers have found that by blocking a gene called beta1-integrin the growth of tumor cells can be stopped. When this gene was removed the tumor cells quit growing. You don’t have to accept the genes that you were given at birth. Gen Cells Cures will be able to manipulate your genes to cure your breast cancer.
Our Cancer Stem Cell and Genomics program will bring together the top scientific minds in the world under one tin roof to maximize the use of diverse approaches to the understanding of cancer genomics fused with stem cell solutions. Gen Cells Cures isn’t seeing for a multi-million dollar biomedical explore town like the Stowers design in Kansas City, which is a medical town to be admired. A rented tin shack will do just fine. Of course, we would accept hand-me down michroscopes from the Stoweres (billionaires who bought their own multi-million dollar biomedical explore center) if they would be gracious adequate to grant them to us or we would accept a small prime the pump check to move send with our research. The Stowerses and all the scientists from the Stowers design have an open invitation to visit our lab in the Caribbean. What we are seeing for is a cure for breast cancer to stop the humiliation, pain and suffering this menace to society causes millions of women and thousands of men worldwide, and not a new biomedical center… Every dollar invested with us goes into pure medical explore and equipment. The same offer goes out to all the millionaires and especially the billionaires of the world. habitancy that come to mind are: Paul Allen, Bill and Melinda Gates, Jon Huntsman, William and Alice Goodman, Ann Lurie, Jamie and Karen Moyer, Harold C. Simmons, Alfred Mann, Sumner M. Redstone, Michael Milton and the Palm beach billionaires, there are naturally too many to mention. The combined wealth of the three Microsoft billionaires alone is more than ten times the whole spent by the U.S. Federal Government on explore to fight cancer and other deadly diseases. We know we’re in the wrong firm to come to be billionaires ourselves. This kind of biotechnology has never produced even one billionaire. It’s the cure for breast cancer that we want.
Simply put the cancer explore organizations are funding the wrong researchers. It’s time to go outside the normal explore channels. Do something different. The same story year after year after year and no cure. These unmotivated researchers just aren’t getting results. Let man else have a shot at it. It’s time to try something new and different. A dissimilar approach. There are races for the cure, golf tournaments for the cure, there are walks for the cure, there are foundations for the cure. These foundations have been funding the same ineffective explore for more than twenty years now. These foundations have been betting on the wrong horse. Joining the hunt won’t help if the explore being done doesn’t take on a twenty-first century scientific approach. It’s been time to move send scientifically for five years now. But today’s breast cancer researchers are stuck in a twentieth century mind-set. The Excuse is someday we’ll find the cure, but someday doesn’t help today’s victims of breast cancer. We need top notch scientific operation today.
The genetics are out of the bottle and stem cell explore is piquant send whether the U.S. Government likes it or not. Gen Cells Cures has moved off-shore to the Caribbean to avoid the political controversy over stem cell research. I am sure you won’t mind a walk on the beach with me to talk about your cure for your breast cancer. Once we have the cure we can take the cure from the bench to the inpatient without a long and precious wait for Fda approval. There are many advantages to not having big brother breathing down your neck. The governments of the United States and Western countries have nothing to offer except road blocks, red tape and detours. Our patients don’t have time for political smoke and mirrors. With a dinky luck we could have your cure before the time comes that you need that dreaded surgical operation and chemo.
Our gifted world-class researchers are visionary and have been schooled in winning and have courage, creativity, can-do attitudes, burning desires, unfaltering belief and an obsession that they will be there first. By first we mean years ahead of the other biotechnology companies. Like determined, fighting Nascar drivers our scientists are living to take the chequered flag of biotech and win the coveted race for the cure for breast cancer.
Focused on breakthrough discoveries, Gen Cells Cures nurtures a culture that encourages high standards of excellence, former thinking, hard work and a willingness to take risks. Our world-renowned scientists believe in themselves and its belief that gets us there. The firm will seek to design a work environment that is results focused and team-orientated. We compete against time. Though we compete intensely we declare high ethical standards and trust and respect for each other. Quality is the cornerstone of all our activities. We seek the highest Quality information, decisions and people. Our success depends on excellent scientific innovation. We see the scientific formula as a multi-step process which includes designing the right experiment, collecting and analyzing data and rational decision making. It is not subjective or emotional but rather a logical, open and rational process.
Our success comes from one straightforward fact; we are committed to being a science-based, patient-driven company, driven by that one special breast cancer patient…you.
Gen Cells Cures lost most of our one million dollar start-up money in offshore bank scandal and currency devaluation last year. We are now actively pursuing financial support. Unfortunately, the Gen Cells Cures team is made up of great scientific minds and not great marketers, salesmen, or fund raisers. Yes, we are seeing for a millionaire or billionaire without a cause to maintain our work, but if you are not our wealthy saviour, we welcome any help, be it financial or a donation of your time. The scientific team is on stand-by. What we’re lacking is the funding to go forward. We could use motivated salesmen to sell our research, fund raisers, skilled internet marketers or man just to pass out flyers or mail out promotional material. We could use help from the media with publicity stories, ads and promotions to get the word out. We are particularly concerned in seeing for aid from the billionaires of the world; there are almost 600 in the world. Billionaires like Sergey Brin and Larry Page (Google billionaires), Rupert Murdoch, Ted Turner, and Oprah Winfrey and others who control the media could get our life-saving message to the world fast. We are also hoping that some of my celebrities friends will come send and spread their wings to help maintain our breast cancer research: Steven Seagal, Charlie Sheen, Wesley Snipes, Danny Glover, Erik Estrada, Tom Arnold, Dolph Lundgren, Roger Clinton, Bill Clinton, Usher, Hulk Hogan, Ivana Trump, John Secada, Sylvester Stalone, Arnold Schwarzenegger, Mike Reno, Richard Branson, Cindy Crawford, Cher, Demi Moore, Michelle Pfeiffer, and other stars that I have had the good fortune of meeting in man and others celebrities that I hope to meet in the future. (Photos of Gerald and the stars can be viewed at his promotional group listed below.) I am waiting to get my photo with Suzanne Summers!
Gen Cells Cure offers more than hope. We can do the job. If you’re going to eradicate cancer you have to have the right habitancy doing the right research. One thing is for sure. We couldn’t do any worse than what the scientists before us have done. Which is virtually nothing! Help us alleviate the pain and suffering. Together, with your help, we can cure breast cancer.
Article by Gerald Armstrong- scientist0707@yahoo.com
Gerald is the owner of Gen Cells Cures
Visit his group for facts about “The Cure” for incurable diseases and aging.
Group address [http://www.msnusers.com/cures]